mycophenolic-acid and West-Nile-Fever

mycophenolic-acid has been researched along with West-Nile-Fever* in 2 studies

Other Studies

2 other study(ies) available for mycophenolic-acid and West-Nile-Fever

ArticleYear
West Nile Virus Infection in Liver Transplant Recipient With Neither De Novo Infection nor Donor-Derived Infection: A Case Report.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2023, Volume: 21, Issue:1

    West Nile virus was first described in 1937 and has sinceperiodically appearedin variousparts oftheworld by infecting people and horses. Reported infection symptoms and signs may be highly variable, ranging from fever and myalgias to meningoencephalitis. A 59-year-old patient was admitted to the University Clinical Centre of Serbia, Belgrade, in September 2018, where livertransplantwasperformedtotreat cirrhosisof ethyl etiology. Immunosuppressive therapy was started immediately after successful transplant, with the patientreceiving methylprednisolone, tacrolimus, and mycophenolate mofetil. Mycophenolate mofetil was excluded from therapy on postoperative day 3 because of progressively worse white blood cell count. The patient became febrile on postoperative day 11 (39.6 °C), and arm tremor, nausea, vomiting, and frequent fluid stools occurred. He complained of pain in the muscles and joints of the lower extremities. The next day he experienced occasional disorientation. Neurological findings revealed no signs of acute focal neurological deficit. We performed culture tests to isolate pathological microorganisms, and results were negative in cultures of the blood, urine, feces, ascites, and a smear of the wound and tip of the central venous catheter. Lumbar puncture resulted in a clear cerebrospinal fluid that was sent for analysis that showed significant increases in white blood cell count (94 × 106 cells/L), total proteins (1.61 g/L), and microalbumin (504.5 mg/L), with a reduction of immunoglobulin G. On postoperative day 15, positive serology of West Nile virus immunoglobulin M in cerebrospinal fluid was verified. Intensive monitoring and symptomatic and supportive therapy resulted in clinical and laboratory improvement, and the patient was discharged in good general condition on postoperative day 22. Considering the high risk of posttransplant complications, there remains the question of whether all donors and recipients should be tested forWest Nile virus atthe onset oftransplant.

    Topics: Animals; Horses; Kidney Transplantation; Liver Transplantation; Male; Mycophenolic Acid; West Nile Fever; West Nile virus

2023
[West Nile meningoencephalitis in an immunocompromised patient].
    Revue neurologique, 2008, Volume: 164, Issue:12 Suppl

    Topics: Anti-Inflammatory Agents; Coma; Cyclosporine; Dopamine Agents; Enzyme-Linked Immunosorbent Assay; Fatal Outcome; Humans; Immunocompromised Host; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Kidney Transplantation; Levodopa; Magnetic Resonance Imaging; Male; Meningoencephalitis; Mycophenolic Acid; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; West Nile Fever; West Nile virus; Young Adult

2008